User profiles for "author:Eduardo L Franco"

Eduardo L. Franco, Professor

McGill University
Verified email at mcgill.ca
Cited by 51610

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the …

D Saslow, D Solomon, HW Lawson… - American journal of …, 2012 - academic.oup.com
An update to the American Cancer Society (ACS) guideline regarding screening for the early
detection of cervical precancerous lesions and cancer is presented. The guidelines are …

Epidemiology and transmission dynamics of genital HPV infection

AN Burchell, RL Winer, S de Sanjosé, EL Franco - Vaccine, 2006 - Elsevier
This chapter provides an overview of the epidemiology of human papillomavirus (HPV)
infection, with a focus on the dynamics of sexual transmission. We explore concepts related …

Comprehensive control of human papillomavirus infections and related diseases

FX Bosch, TR Broker, D Forman, AB Moscicki… - Vaccine, 2013 - Elsevier
Infection with human papillomavirus (HPV) is recognized as one of the major causes of
infection-related cancer worldwide, as well as the causal factor in other diseases. Strong …

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

DM Harper, EL Franco, C Wheeler, DG Ferris… - The lancet, 2004 - thelancet.com
Background Vaccination against the most common oncogenic human papillomavirus (HPV)
types, HPV-16 and HPV-18, could prevent development of up to 70% of cervical cancers …

[HTML][HTML] Sustained efficacy up to 4· 5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised …

DM Harper, EL Franco, CM Wheeler, AB Moscicki… - The Lancet, 2006 - thelancet.com
Background Effective vaccination against HPV 16 and HPV 18 to prevent cervical cancer will
require a high level of sustained protection against infection and precancerous lesions. Our …

[HTML][HTML] Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer

MH Mayrand, E Duarte-Franco… - … England Journal of …, 2007 - Mass Medical Soc
Background To determine whether testing for DNA of oncogenic human papillomaviruses
(HPV) is superior to the Papanicolaou (Pap) test for cervical-cancer screening, we …

Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer

EL Franco, LL Villa, JP Sobrinho… - The Journal of …, 1999 - academic.oup.com
Acquisition and clearance of cervical human papillomavirus (HPV) infection were analyzed
among 1425 low-income women attending a maternal and child health program in São …

Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia

NF Schlecht, S Kulaga, J Robitaille, S Ferreira… - Jama, 2001 - jamanetwork.com
ContextHuman papillomavirus (HPV) infection is believed to be the central cause of cervical
cancer, although most of the epidemiological evidence has come from retrospective, case …

The epidemiology of genital human papillomavirus infection

H Trottier, EL Franco - Vaccine, 2006 - Elsevier
Clinical and subclinical human papillomavirus (HPV) infections are the most common
sexually transmitted infections in the world, and most sexually-active individuals are likely to …

Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection

EL Franco, E Duarte-Franco, A Ferenczy - Cmaj, 2001 - Can Med Assoc
ORGANIZED SCREENING HAS CONTRIBUTED TO A DECLINE in cervical cancer
incidence and mortality over the past 50 years. However, women in developing countries …